Dermatology Excimer Laser Market Size, Growth and Forecast 2032

Market Overview

Dermatology Excimer Laser Market size was valued at USD 609.4 million in 2024 and is anticipated to reach USD 1,306.3 million by 2032, growing at a CAGR of 10% during the forecast period.

The Dermatology Excimer Laser Market features strong competition among key players such as Cutera, Inc., The Daavlin Company, Alma Lasers, DEKA Research & Development Corp, Shenzhen GSD Tech Co., Ltd., Fotona, Lumenis, Ra Medical Systems, Hologic, and Strata Skin Sciences. These companies focus on expanding product portfolios through technological advancements, strategic collaborations, and new product launches to strengthen global reach. Innovations in portable laser systems and precision treatment devices continue to drive adoption in both therapeutic and cosmetic applications. North America leads the Dermatology Excimer Laser Market with a 39% share in 2024, supported by advanced healthcare infrastructure, high adoption of laser-based treatments, and strong demand for non-invasive dermatological procedures.

Market Insights

• The Dermatology Excimer Laser Market was valued at USD 609.4 million in 2024 and is expected to reach USD 1,306.3 million by 2032, growing at 10%.
• North America leads the market with a 39% share in 2024, driven by advanced healthcare systems and high adoption of non-invasive dermatology treatments.
• The trolley-mounted devices segment dominates with a 46% share, supported by precision, ergonomic design, and suitability for large-scale clinical use.
• The psoriasis treatment segment holds a 42% share, benefiting from high remission rates, shorter procedures, and increasing awareness of phototherapy.
• Dermatology clinics lead the end-user segment with 48%, boosted by rising cosmetic procedures, availability of skilled professionals, and expanding clinic networks.

Market Segment Insights

By Product Type:

The trolley-mounted devices segment dominates the Dermatology Excimer Laser Market, accounting for 46% of total revenue in 2024. These systems offer superior precision, stable beam output, and suitability for high-volume clinical use. Hospitals and large dermatology centers prefer them for treating chronic skin disorders due to consistent wavelength accuracy and ergonomic design. Their advanced cooling systems and user-friendly interfaces further strengthen their adoption across developed regions, driving continued demand growth in professional dermatology practices.

• For instance, Strata Skin Sciences has a worldwide installed base of over 2,000 Xtrac devices, which are praised for their targeted 308nm wavelength and user-friendly features, as evidenced by company reports and clinical studies.

By Application:

The psoriasis treatment segment leads the Dermatology Excimer Laser Market with a 42% share in 2024. It benefits from the rising prevalence of psoriasis and the proven effectiveness of excimer lasers in localized plaque management. High remission rates, shorter treatment durations, and fewer side effects than systemic therapies promote adoption. Increasing awareness about phototherapy’s clinical benefits and supportive reimbursement policies in North America and Europe further enhance the segment’s strong market presence.

• For instance, PhotoMedex Inc. announced enhanced treatment outcomes using its XTRAC excimer laser system, achieving over 80% lesion clearance after multiple sessions.

By End User:

The dermatology clinics segment holds the largest share of 48% in the Dermatology Excimer Laser Market in 2024. Clinics are key treatment centers offering targeted therapy with reduced wait times and lower costs than hospitals. The availability of portable devices and skilled dermatologists enables higher patient throughput and procedure frequency. Growing cosmetic dermatology trends and expanding clinic networks across urban and semi-urban areas continue to fuel market growth within this end-user category.

Key Growth Drivers

Rising Prevalence of Chronic Skin Disorders

The increasing incidence of psoriasis, vitiligo, and atopic dermatitis drives demand for excimer laser treatments. These devices provide targeted, non-invasive therapy with minimal side effects, making them a preferred option over conventional phototherapy. The growing patient population requiring long-term management enhances the adoption rate in hospitals and dermatology clinics, supporting sustained revenue growth across developed and emerging markets.

Advancements in Laser Technology

Ongoing innovation in excimer laser systems enhances precision, energy efficiency, and treatment speed. The integration of compact designs, adjustable wavelengths, and digital control interfaces allows clinicians to customize therapy for varying skin conditions. Improved patient safety and shorter treatment durations strengthen clinical acceptance, particularly in outpatient and cosmetic settings. These advancements position excimer lasers as essential tools in modern dermatology treatment protocols.

• For instance, Alma Medical Systems' Excimer Pro model delivers monochromatic 308-nm UVB light, specifically targeted for the treatment of localized psoriasis and vitiligo. It does not have multi-wavelength capabilities.

Expanding Cosmetic Dermatology Applications

Rising consumer awareness and demand for aesthetic skin restoration accelerate market expansion. Excimer lasers are increasingly used in cosmetic procedures for pigmentation correction and scar reduction. The growing number of dermatology and cosmetic clinics offering laser-based treatments contributes significantly to revenue. Economic growth, urbanization, and a rise in disposable incomes further boost patient willingness to invest in laser procedures for both therapeutic and cosmetic purposes.

• For instance, Cutera Inc. introduced the next-generation excel V™+ platform featuring enhanced precision for treating vascular lesions and pigmented skin imperfections, enabling faster patient recovery.

Key Trends & Opportunities

Shift Toward Portable and Handheld Devices

Miniaturization and design improvements have led to the growing popularity of handheld and table-top excimer lasers. These devices enable flexible, point-of-care treatments and suit smaller clinics and ambulatory centers. Their lower cost and ease of use expand access in developing countries. Manufacturers are investing in portable systems that deliver comparable efficacy to larger models, creating new opportunities in emerging markets with limited healthcare infrastructure.

• For instance, the Excimer 5000C from Kernel emits a targeted 308 nm UVB light for vitiligo treatment, featuring adjustable energy output and integrated cooling, designed for fast, non-invasive sessions suitable for varied skin types.

Integration of Artificial Intelligence and Automation

AI-based control systems are being integrated into excimer laser platforms for precise energy modulation and personalized treatment. Automated calibration and real-time skin feedback enhance safety and efficiency. This trend improves consistency in clinical outcomes and reduces operator dependency. The combination of smart technologies and cloud-based data tracking supports predictive maintenance and treatment analytics, creating a pathway for advanced, technology-driven dermatology care.

• For instance, in laser additive manufacturing, SCANLAB’s motion control paired with the AI platform AMAIZE allows point-wise power optimization on each scan vector, enabling automated parameter tuning and improved consistency.

Key Challenges

High Equipment and Maintenance Costs

Excimer laser systems involve significant upfront investment and recurring maintenance expenses. Smaller clinics and centers often find these costs prohibitive, limiting widespread adoption. The need for trained technicians and costly consumables adds further operational burden. These financial barriers, especially in developing regions, slow market penetration despite growing demand for advanced dermatological treatments.

 Limited Access in Emerging Economies

Infrastructure gaps and low awareness among dermatologists restrict excimer laser usage in emerging countries. High import duties and limited distribution networks reduce accessibility. Patients in rural areas remain dependent on traditional or systemic therapies. Expanding training programs, cost-effective models, and government support will be essential to overcome these limitations and unlock new market opportunities globally.

Risk of Side Effects and Overexposure

Despite clinical benefits, improper use of excimer lasers can lead to erythema, blistering, or pigment changes. Inadequate operator training and poor calibration increase these risks. Such adverse outcomes may reduce patient confidence and discourage adoption. Manufacturers and regulatory bodies emphasize safety certifications, operator training, and quality control to ensure effective and risk-free laser-based dermatological procedures.

Regional Analysis

North America

North America dominates the Dermatology Excimer Laser Market with a 39% share in 2024. The region’s leadership stems from advanced healthcare infrastructure, high awareness of dermatological treatments, and early adoption of laser technology. Strong regulatory frameworks and reimbursement policies support clinical use in hospitals and dermatology centers. The presence of major manufacturers investing in research and innovation further strengthens market growth. Rising cases of psoriasis and vitiligo, coupled with strong cosmetic treatment demand, continue to drive revenue. The U.S. remains the primary contributor to regional market expansion.

Europe

Europe holds a 28% share of the Dermatology Excimer Laser Market, supported by well-established dermatology care systems and growing patient awareness. Increasing demand for non-invasive procedures and phototherapy for chronic skin disorders drives adoption. Germany, France, and the U.K. lead in excimer laser utilization due to favorable insurance coverage and high practitioner expertise. The expansion of outpatient dermatology clinics and the introduction of compact laser devices enhance accessibility. It continues to see growth from both therapeutic and aesthetic applications across urban centers.

Asia-Pacific

Asia-Pacific accounts for a 22% share in the Dermatology Excimer Laser Market and represents the fastest-growing region. Rising disposable income, expanding medical tourism, and growing prevalence of skin diseases fuel adoption. Countries such as China, Japan, and South Korea are major contributors, driven by rapid technology integration and cosmetic dermatology trends. Government initiatives supporting advanced medical equipment further boost adoption in hospitals and clinics. Increasing investments by global players to establish regional distribution networks strengthen the market presence.

Latin America

Latin America captures a 6% share in the Dermatology Excimer Laser Market. The region benefits from increasing dermatological awareness and gradual modernization of healthcare facilities. Brazil and Mexico lead adoption, driven by expanding private clinics and growing demand for aesthetic laser treatments. Cost constraints and limited access to advanced equipment remain barriers. However, rising partnerships with international manufacturers are improving availability. It is expected to experience moderate growth through expanding dermatology practices and technology transfer programs.

Middle East & Africa

The Middle East & Africa holds a 5% share of the Dermatology Excimer Laser Market. Growth is supported by improving healthcare infrastructure and rising focus on skin health in urban areas. Wealthy Gulf nations, including the UAE and Saudi Arabia, show high adoption in specialized clinics. Africa remains in the early adoption stage due to cost and infrastructure limitations. Increasing training initiatives for dermatologists and growing cosmetic awareness are gradually supporting market entry. It continues to show potential for long-term expansion.

Market Segmentations:

By Product Type:

• Trolley Mounted Devices
• Table-Top Devices
• Handheld Devices

By Application:

• Psoriasis Treatment
• Vitiligo Treatment
• Atopic Dermatitis
• Alopecia Areata
• Leukoderma
• Others

By End User:

• Hospitals
• Dermatology Clinics
• Cosmetic Clinics
• Ambulatory Surgical Centers (ASCs)

By Region:

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Competitive Landscape

The Dermatology Excimer Laser Market is characterized by strong competition among global and regional players focused on product innovation, strategic partnerships, and market expansion. Key companies include Cutera, Inc., The Daavlin Company, Alma Lasers, DEKA Research & Development Corp, Shenzhen GSD Tech Co., Ltd., Fotona, Lumenis, Ra Medical Systems, Hologic, and Strata Skin Sciences. These firms emphasize technological advancements, such as improved wavelength control, compact device designs, and enhanced user interfaces, to expand their clinical applications. Continuous investments in R&D and regulatory approvals for new models strengthen their market positions. Partnerships with dermatology clinics and hospitals help expand global distribution networks. Companies are also adopting digital marketing and service-based business models to enhance accessibility and customer loyalty. Competitive differentiation increasingly depends on device portability, cost-efficiency, and therapeutic precision, with top players focusing on delivering integrated, patient-centered solutions that meet both medical and aesthetic dermatology needs.

Key Players

• Cutera, Inc.
• The Daavlin Company
• Alma Lasers
• DEKA Research & Development Corp
• Shenzhen GSD Tech Co., Ltd.
• Fotona
• Lumenis
• Ra Medical Systems
• Hologic
• Strata Skin Sciences

Recent Developments

• In May 2025, STRATA Skin Sciences announced a historic expansion after updated CPT codes removed some reimbursement barriers.
• On May 19, 2025, STRATA Skin Sciences secured approval for revisions to CPT codes 96920-96922, expanding reimbursement eligibility for 308 nm excimer laser treatments to include inflammatory and autoimmune skin diseases beyond psoriasis.
• In July 2024, XTRAC Momentum 1.0 device from STRATA Skin Sciences, Inc. was approved by Japan’s Ministry of Health, Labor and Welfare. The device was launched in the U.S in early 2022 and became available in Japan via STRATA’s partners JMEC Co. Ltd. STRATA’s excimer devices are used in over 300 hospitals and dermatology clinics across Japan.

Report Coverage

The research report offers an in-depth analysis based on Product Type, Application, End User and Regiossn. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

1. Demand for targeted phototherapy will continue rising with increasing chronic skin conditions.
2. Portable and handheld laser systems will gain stronger acceptance in clinics and home care.
3. Integration of AI and automation will enhance precision and treatment consistency.
4. Cosmetic dermatology applications will expand due to growing aesthetic awareness.
5. Technological upgrades will improve device safety, cooling systems, and energy efficiency.
6. Emerging markets in Asia-Pacific and Latin America will offer new growth opportunities.
7. Strategic collaborations between manufacturers and clinics will strengthen product adoption.
8. Digital platforms will support tele-dermatology and remote treatment monitoring.
9. Sustainability and eco-efficient device designs will influence future product development.
10. Training programs for dermatologists will boost operational expertise and patient safety.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.